Head to Head Stocks: Costco Wholesale Corporation (NASDAQ:COST), Global Blood Therapeutics, Inc. (NASDAQ:GBT)

Costco Wholesale Corporation (NASDAQ:COST)

Costco Wholesale Corporation (NASDAQ:COST) closed at $204.76 on the last trading session with an increase of 0.52%, whereas, it previously closed at $203.71. The company has a market capitalization of $92.36 Billion. The company traded shares of 2.14 Million on the trading day while its three month average volume stands at 2.83 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Costco Wholesale Corporation (NASDAQ:COST) produced diluted EPS of 7.42. The EPS estimate for next year as estimated by analysts is at 8.38 while EPS for next quarter is estimated at 1.69. Earnings per Share growth for this year is reported at 17.5, while the analysts estimated the EPS growth for next year at 8.38% and Earnings growth for next 5 years stands at 11.12% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Costco Wholesale Corporation (NASDAQ:COST) is at 27.6 while the forward p/e is at 24.43. The P/S or Price to Sales ratio of Costco Wholesale Corporation (NASDAQ:COST) stands at 0.64 and Price to Book or P/B for the most recent quarter stands at 6.83. The Price to Free Cash Flow ratio or P/FCF is reported at 49.23. The quick ratio and the current ratio of Costco Wholesale Corporation (NASDAQ:COST) are reported at 0.5 and 1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Costco Wholesale Corporation (NASDAQ:COST) stands at 8, 26.2 and 16.4 respectively

The trailing twelve month Revenue of Costco Wholesale Corporation (NASDAQ:COST) is reported at 144.84 Billion with income of 3.28 Billion. The outstanding shares of Costco Wholesale Corporation (NASDAQ:COST) are 451.05 Million. The institutional Ownership of the shares of 72.8 stands at 0.80%, this figure is decreased -0.82 in the last six months. The insider ownership for the shares of Costco Wholesale Corporation (NASDAQ:COST) is ticked at 0.4%, the figure is plummeted -4.52% in the last six months.

Some other important financial aspects to be discussed here for Costco Wholesale Corporation (NASDAQ:COST) is the Mean Target Price estimated by the analysts which stands at 240.26. The 52 week high of Costco Wholesale Corporation (NASDAQ:COST) is placed at 245.16 and 52 week low is standing at 175.79.

Performance wise the shares of Costco Wholesale Corporation (NASDAQ:COST) rose up 7.77% for the week, it also fell -11.36% for the monthly performance, while for the quarter it went up -12.74%. The shares decrease -1.55% for the half year and flew up for the Year-To-Date performance. The shares of Costco Wholesale Corporation (NASDAQ:COST) grew 10.02% for the yearly performance.

Global Blood Therapeutics, Inc. (NASDAQ:GBT)

Global Blood Therapeutics, Inc. (NASDAQ:GBT) closed at $41.13 on the last trading session with an increase of 0.19%, whereas, it previously closed at $41.05. The company has a market capitalization of $2.18 Billion. The company traded shares of 731482 on the trading day while its three month average volume stands at 1.37 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT) produced diluted EPS of -3.42. The EPS estimate for next year as estimated by analysts is at -3.63 while EPS for next quarter is estimated at -0.89. Earnings per Share growth for this year is reported at -11.3, while the analysts estimated the EPS growth for next year at -3.63% and Earnings growth for next 5 years stands at 37% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Global Blood Therapeutics, Inc. (NASDAQ:GBT) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Global Blood Therapeutics, Inc. (NASDAQ:GBT) stands at 0 and Price to Book or P/B for the most recent quarter stands at 4.53. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Global Blood Therapeutics, Inc. (NASDAQ:GBT) are reported at 14.6 and 14.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Global Blood Therapeutics, Inc. (NASDAQ:GBT) stands at -33.6, -36.2 and 0 respectively

The trailing twelve month Revenue of Global Blood Therapeutics, Inc. (NASDAQ:GBT) is reported at 0 with income of -166200000. The outstanding shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT) are 53.02 Million. The institutional Ownership of the shares of 97.7 stands at 0.80%, this figure is increased 2.51 in the last six months. The insider ownership for the shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT) is ticked at 4.3%, the figure is plummeted -2.05% in the last six months.

Some other important financial aspects to be discussed here for Global Blood Therapeutics, Inc. (NASDAQ:GBT) is the Mean Target Price estimated by the analysts which stands at 87. The 52 week high of Global Blood Therapeutics, Inc. (NASDAQ:GBT) is placed at 68.05 and 52 week low is standing at 30.15.

Performance wise the shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT) rose up 9.5% for the week, it also rise 28.49% for the monthly performance, while for the quarter it went down 11.46%. The shares decrease -4.13% for the half year and flew up for the Year-To-Date performance. The shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT) grew 4.52% for the yearly performance.